Author

K. U. Wong

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

C. Deng· 2 shared H. Wang· 2 shared A. H. Wong· 1 shared A. H.-H. Wong· 1 shared F. Xing· 1 shared J. Shi· 1 shared K. H. Wong· 1 shared L. Jiang· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

C. Deng

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivDec 28, 2021

Assessment of chimeric antigen receptor T (CAR-T) cytotoxicity by droplet microfluidics in vitro

K. U. Wong, J. Shi, P. Li…·A. H.-H. Wong

This study presents a droplet microfluidic assay to assess CAR-T cytotoxicity in vitro, enabling analysis of activity, expansion, and mechanism under varying conditions.

DOI 10.1093/abt/tbac008

experimental assaycell type annotation

𝕏 PostBluesky

Cell BiologybioRxivPreprintAug 27, 2019

Dissecting the dilemma between in vitro and in vivo drug screening: treating HepG2 cells with Artesunate as a model

K. U. Wong, S. L. Shi, H. Wang…·C. Deng

This study compares in vitro and in vivo drug responses to Artesunate in HepG2 cells, finding discrepancies in efficacy and biomarker expression.

DOI 10.1101/499723

humanbulk RNA-seq

𝕏 PostBluesky